Clarivate

OCTOBER 25, 2023

Humira, the long-running blockbuster autoimmune drug, was not eligible for negotiations since it will have nine biosimilars on the market by the end of 2023. IMBRUVICA® and STELARA® are universally covered on the specialty tier, with Enbrel® on the specialty tier for all but a handful of plans (Clarivate 2023 Part D formulary data).

Prescription 52

Prescription Physicians Manufacturing Healthcare 52

pharmaphorum

SEPTEMBER 30, 2022

The approval makes Relyvrio (sodium phenylbutyrate and taurursodiol) the first new therapy option for ALS – also known as motor neuron disease (MND) – since Mitsubishi Tanabe Pharma’s intravenous Radicava (edaravone) was cleared by the FDA in 2017. An oral version of edaravone was cleared this year. Bad news for Biohaven.

FDA 98

FDA Doctors Patients Prescription 98

Contrarian Sales Techniques

FEBRUARY 25, 2023

The film features interviews with activists, physicians, and other experts who discuss the challenges and injustices that arose from the AIDS epidemic and the global response. Most pharma companies that distribute meds here in Malaysia did not manufacture their own product. billion (~USD 316 million) Duopharma Biotech Berhad: MYR 1.88

Marketing 52

Marketing Distribution Medical Government 52

PM360

JULY 13, 2023

Launched in April 2023, BrightInsight’s PSP+ Companion App, built on the compliant BrightInsight Platform, connects patients to the resources they need to complete prior authorization, register for financial assistance, understand and track their therapies, and much more. But outdated manual processes are complex and leave many patients out.

Education 89

Education Medical Media Patients 89

PM360

AUGUST 9, 2022

Levrx also engages physician groups and members directly, giving healthcare consumers the information needed at the point of care to keep costs low, avoid prescription rewrites, and prevent cost-related non-adherence. andrew.mills@caretrack.com CareTrack Health is a fully integrated physician practice extension. CareTrack Health.

Prescription 105

Prescription Medical Side effects Patients 105

PM360

AUGUST 24, 2023

biosimilars market is evolving rapidly and pharma marketing programs need to evolve as well to better meet physician needs. As we found in our latest physician survey, physicians are actively seeking more information on key topics such as patient affordability, patient eligibility, clinical results, formulary coverage, and more.

Marketing 97

Marketing Physicians Electronics Side effects 97

European Pharmaceutical Review

APRIL 10, 2024

Over the past decade, there has been an increase in discussions involving industry stakeholders, regulatory agencies, and physicians about developments in the emerging microbiome therapeutics industry. During the development of clinical trials that use faecal-derived material, the necessity of safety is paramount.

Safety 83

Safety Patients Medical FDA 83

PM360

APRIL 7, 2023

Importance of Data Collection Many manufacturers fail to allocate sufficient time to obtain the safety and efficacy data needed to define critical endpoints. The accumulation of the right data—including safety, efficacy, and outcomes—are vital to negotiations with payers as opposed to what regulators are looking for. DeFeudis, Nicole.

Manufacturing 52

Manufacturing Marketing Patients Safety 52

European Pharmaceutical Review

DECEMBER 27, 2023

Second, the production and delivery of CAR T cells necessitates close collaboration between the pharma industry and academic (usually transplant) departments. 10 Benefits of point-of-care CAR T-cell therapy Even after validation of the efficacy and safety of the therapy, two critical challenges remained – affordability and accessibility.

Manufacturing 83

Manufacturing Food and Drug Administration Patients Pharma 83